openPR Logo
Press release

Investigation announced for Investors in shares of Contura Energy, Inc. (NYSE: CTRA)

07-30-2020 01:40 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Contura Energy, Inc. (NYSE: CTRA) shares over potential securities laws violations.

An investigation for investors in Contura Energy, Inc. (NYSE: CTRA) shares over potential securities laws violations.

An investigation was announced concnering potential securities laws violations by Contura Energy, Inc. in connection with certain financial statements.

Investors who purchased shares of Contura Energy, Inc. (NYSE: CTRA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Contura Energy, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

In December 2017, Contura Energy, Inc sold several of its mines and other assets to Blackjewel L.L.C. In November 2018, Contura Energy, Inc merged with Alpha Natural Resources Holdings, Inc. and ANR, Inc. (the “Merger”). According to the registration statement issued in connection with the Merger, Contura disclosed that it had agreed to backstop certain of Blackjewel’s bonding obligations to facilitate the permit transfer for the mines and that Blackjewel would enter into financing by June 30, 2019 sufficient to release Contura from such obligations.

On July 1, 2020, Blackjewel filed for Chapter 11 bankruptcy. Contura Energy, Inc repurchased the mines and sold the same assets to Eagle Specialty Materials, LLC, whereby Contura would pay $90 million to Eagle Specialty to acquire the mines and assume the related reclamation obligations.

Shares of Contura Energy, Inc. (NYSE: CTRA) declined from $79.20 per share in Octboer 2018 to as low as $1.93 per share on March 24, 2020.

Those who purchased shares of Contura Energy, Inc. (NYSE: CTRA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Contura Energy, Inc. (NYSE: CTRA) here

News-ID: 2099300 • Views: 380

More Releases from Shareholders Foundation

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Alert: Investigation over pot …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vanda Pharmaceuticals Inc. (NASDAQ: VNDA. Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those Vanda Pharmaceuticals Inc. (NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Vanda Pharmaceuticals Inc. (NASDAQ: VNDA
Investigation announced for Long-Term Investors in shares of Milestone Pharmaceu …
Certain directors of Milestone Pharmaceuticals Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) and currently hold any of those NASDAQ: MIST shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Milestone Pharmaceuticals directors breached their fiduciary duties and caused damage to the
Investigation announced for Long-Term Investors in shares of iQIYI, Inc. (NASDAQ …
An investigation was announced for investors in shares of iQIYI, Inc. (NASDAQ: IQ) concerning potential breaches of fiduciary duties by certain directors and officers of iQIYI, Inc.. Investors who are current long term investors in iQIYI, Inc. (NASDAQ: IQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IQ
Investigation announced for Investors in shares of Noble Energy, Inc. (NASDAQ: N …
An investigation was announced concerning whether the takeover of Noble Energy, Inc.is unfair to: NBL stockholders. Investors who purchased shares of Noble Energy, Inc. (NASDAQ: NBL) and currently hold any of those NASDAQ: NBL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Noble Energy, Inc. breached their fiduciary duties

All 5 Releases


More Releases for Contura

New Approach to Facial Aesthetics Market 2023 Research Technology Expand Busines …
This report provides strategic study of the Global Facial Aesthetics Market, and the growth forecast for the period 2014 to 2023. The scope of the report includes competitive analysis of various market segments based on key trends, competitive landscape analysis and key regional development status. This study provides insights about the Facial Aesthetics Market in regards to its uses, benefits and in-depth look at Research. This Report provide in-depth updated information
Facial Aesthetics Market (2019 – 2023) is Booming Worldwide; Top Key Vendors- …
The Facial Aesthetics Market research report provided by Crystal Market Research (CMR) is the most detailed study about Facial Aesthetics that is estimated to grow at a tremendous rate over the forecast period 2019-2023. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Market Summary: The Facial Aesthetics Market report based on our unique research methodology delivers thorough analytical scrutiny of
Global Facial Rejuvenation Market to 2026| Merz Pharma, Anika Therapeutics, Lume …
Albany, NY, 23rd November : Recent research and the current scenario as well as future market potential of "Global Market Study on Facial Rejuvenation: Botulinum Toxin to Remain Dominant Product Type Through 2026 Owing to Growing Popularity of Minimally Invasive Facial Treatment" globally. This Persistence Market Research (PMR) report examines the Global Facial Rejuvenation Market for the period 20182026. The primary objective of the report is to offer updates and information
Facial Rejuvenation Market 2021 | Merz GmbH & Co. KGaA, Biopolymer GmbH &Co KG, …
Recent findings on the growth of global facial rejuvenation market demonstrate that the demand for such treatments is not restricted to women. Men, especially the younger demographics, and the ones who are fashion industry professionals are becoming key consumers for facial rejuvenation. The fear of undergoing multiple cosmetic surgeries and deforming the existing facial appearance continues to divert more consumers for facial rejuvenation, which is essentially a combination cosmetic surgery.
Facial Aesthetics 2018 Global Market Key Players – Allergan, Anika Therapeutic …
The Facial Aesthetics Market is expected to witness considerable growth over the forecast period. Consumers are progressively concentrating on individual prepping and decide on stylish items, for example, botulinum poison, dermal fillers, substance peel, and microdermabrasion. Factors, for example, expanded awareness through internet based life, broad promoting of these strategies, and expanded media scope, will help their reception in Brazil, USA, and Venezuela. Moreover, expansion in restorative treatment among buyers
Facial Aesthetics Market 2018 trends estimates high demand to 2023 | Eminent Pla …
This study provides insights about the Facial Aesthetics Market in regards to its uses and benefits. We at Crystal Market Research (CMR) provide updated information that is beneficial in decision making regarding business investments. Eminent Players: The leading players in the market are Allergan, Anika Therapeutics, Contura, Merz Pharma, Nestlé and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies,